Status:
UNKNOWN
Ivermectin Nasal Drops in Post COVID-19 Parosmia
Lead Sponsor:
Menoufia University
Conditions:
Parosmia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine...
Detailed Description
The current study will be a pilot study for a randomized controlled trial conducted on 60 patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medic...
Eligibility Criteria
Inclusion
- Patients should be more than 18 years old,
- Patients having a history of COVID 19 infection more than three months ago as confirmed by PCR test,
- Patients having a post COVID parosmia,
- Patients having no history of systemic steroid administration over the last one month.
Exclusion
- History of previous nasal surgery,
- Underlying systemic diseases (like diabetes mellitus, hypertension, or autoimmune diseases),
- Hypersensitivity to Ivermectin.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05269030
Start Date
July 1 2022
End Date
March 1 2023
Last Update
May 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Menoufia Faculty of Medicine
Shibīn al Kawm, Menoufia, Egypt, 32511